IP Verse

Human Blood-Derived Products Having Decreased Fibrinolytic Activity And Uses Thereof In Hemostatic Disorders - EP3506915B1

PatentPatent Analysis

EP3506915

PLAS FREE
Application Number
EP17768525A
Filing Date
Aug 31, 2017
Status
Granted And Under Opposition
Feb 2, 2024
Grant Date
Mar 6, 2024
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3506915B1 was granted to Plas Free on Mar 6, 2024 following the initial filing on Aug 31, 2017 under the application number EP17768525A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOTESTDec 5, 2024ADMISSIBLE
MARCHANTDec 4, 2024ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents